US pharma company Eli Lilly pauses trial of antibody drug Trump touted as COVID-19 ‘cure’

US pharma company Eli Lilly pauses trial of antibody drug Trump touted as COVID-19 ‘cure’

Eli Lilly and Co said on Tuesday (US time) that the government-sponsored clinical trial of its COVID-19 antibody treatment similar to one taken by US President Donald Trump has been paused because of a safety concern.

Trump touted the Lilly drug, along with the antibody treatment from Regeneron Pharmaceuticals that he received for his COVID-19, as tantamount to a cure in a video he posted last week.

The announcement comes one day after Johnson & Johnson said it was forced to pause a large high-profile trial of its experimental coronavirus vaccine because a volunteer fell ill. J&J said it does not yet know if that person was given the vaccine or a placebo.

AstraZeneca’s US trial for its experimental COVID-19 vaccine has also been on hold for over a month after a volunteer in its UK study fell ill. Trials of that vaccine resumed in other regions after a brief halt.